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TECHNIQUE FOR SPECIFYING THE FATTY
ACID AT THE SN2 POSITION OF

In order to compensate for the increased levels of unsatur

ACYLGLYCEROL LIPIDS

are removed from the membrane lipids and shunted into
triglyceride formation. The yeast are indicated to overpro

ated fatty acids in the lipids, excess unsaturated fatty acids

duce oils containing polyunsaturated fatty acid With superior

TECHNICAL FIELD

properties.

The present invention is directed to a technique for

US. Pat. No. 5,288,619 to Moore discloses a process for

specifying the fatty acid at the sn2 position of acylglycerol
lipids in biological material. Also provided is an isolated

industrial enZymatic interesteri?cation of a triglyceride
including steps of reacting a triglyceride in an enZyme

SLC1 gene and a probe for its detection.

10

BACKGROUND

15

2- position of the glycerides. The method of making the
margarine oil includes a step of providing a transesteri?ca
20

Chemical Abstracts, Vol. 92, Abstract 17761W, (1980)

glycerol having three fatty acids.
25

inventors isolate the ?rst eucaryotic gene, SLC1 that
encodes a transferase speci?c for the 2 position of glycero

lipids from Saccharomyces cerevisiae.
Determining the biological function(s) and mode of action

30

of individual sphingolipids in multicellular eucaryotes has
proven to be a challenging and un?nished task because of

the great variety of sphingolipids present in such organisms
(1—3, see reference citations beloW). In contrast to this

variety, the unicellular eucaryote Saccharomyces cerevisiae

35

has only one major and tWo minor types of structurally

related sphingolipids. Such simplicity provides a unique
opportunity to study sphingolipid function(s) in an organism
to Which molecular genetic techniques can be readily

applied.

tion reaction mixture comprising stearic acid and triglycer
ide vegetable oil and transesterifying using a 1,3 lipase.
EnZymes from synthetic sources are contemplated, includ

ing yeasts.

risk. Plant seed also consist largely of triacylglycerol

The type of fatty acids present in glycerolipids is deter
mined by enZymes called fatty acyltransferases. The present

garine oil. The margarine oil product has a non-random fatty
acid distribution in Which esteri?ed stearic acid is predomi
nantly distributed in the 1,3-positions While esteri?ed unsat
urated fatty acid moieties are in higher concentration in the

carbon atoms). The length of the fatty acid and degree of
saturation have important dietary consequences for man. For
example, diets rich in saturated fatty acids are associated
With increased risk of coronary artery disease Whereas
monounsaturated fatty acids are associated With decreased

1,3 speci?c lipases.
US. Pat. No. 5,286,633 to BroWn et al. discloses an
enZymatic transesteri?cation method for preparing a mar

All membranes of living cells contain glycerophospho
lipids Which have fatty acid attached to the 1 and 2 carbons
of the 3-carbon glycerol molecule. The fatty acids at these
tWo positions have different numbers of carbon atoms and
degrees of unsaturation (a double bond betWeen the tWo

conversion Zone. The enZymes Which are used are preferably

40

“Characterization of sterol ester synthetase in Saccharomy
ces cerevisiae” discloses that cell free extracts of Saccha

romyces cerevisiae catalyZed the synthesis of fatty acid ester
of sterol from cholesterol, fatty acid, ATP, and CoA or from
cholesterol and fatty acyl CoA. The enZyme involved in the
formation of the ester is acyl-CoA-sterol-O-acyltransferase.

Chemical Abstracts, Vol. 91, Abstract 188621j, (1979)
“Utilization of endogenous diacyl glycerol for the synthesis
of triacylglycerol, phosphatidylcholine and phosphatidyl
ethanolamine by lipid particles from baker’s yeast” discloses
a measurement of the activity of 3 enZymes prepared from
S. cerevisiae in the presence of 1,2-diacylglycerol substrates.

The enZymes include diacylglycerol acyltransferase, choline
phosphotransferase, and ethanolamine phosphotransferase.
Chemical Abstracts, Vol. 88, Abstract 165910b, (1978),
“Glycerolipid biosynthesis in Saccharomyces Cerevisiae”
discloses an investigation of S. cerevisiae dihydroxyacetone

phosphate acyltransferase to determine Whether its activity
and that of glycerol phosphate acyltransferase represent dual

The most abundant sphingolipid in S. cerevisiae is man

nosyldiinositolphosphorylceramide With lesser amounts of

inositolphosphorylceramide and mannosylinositolphospho
rylceramide (4,5). The ceramide moiety contains the sphin
goid long chain base phytosphingosine linked by an amide

catalytic functions of a single membranous enZyme.
45

Chemical Abstracts, Vol. 87, Abstract 129342p, (1977),
“Acyltransferase systems involved in phospholipid metabo

bond to a C26 fatty acid

lism in Saccharomyces cerevisiae” discloses membrane

Synthesis of phytosphingosine initiates With the conden
sation of serine and palmitoyl-CoA catalyZed by serine

preparations of S. cerevisiae catalyZed the acylation of
glycerophosphate, 1 acyl- and 2 acyl-glycerophosphates and
1 acyl- and 2 acyl-glycerylphosphocholines. Speci?city of

palmitoyltransferase
In S. cerevisiae the enZyme
to yieldor3-ketodihydrosphingosine
one of its subunits is encoded

by the LCB1 gene

glycerophosphate acyltransferase, 2-acylglycerophosphate
acyltransferase and 1-acylglycerophosphate acyltransferase

Strains defective in lcb1 lack serine

palmitoyltransferase activity and have an Lcb‘ phenotype
because they require a long chain base such as phytosphin

gosine for groWth (8—10). The Lcb' phenotype provides a
starting point for a molecular genetic analysis of sphin

Were determined.

Chemical Abstracts, Vol. 105, Abstract 94333x, (1986),
55

sn-glycerol-3-phosphate acyltransferase: Simultaneous loss

golipid function(s). Saccharomyces cerevisiae normally
requires sphingolipid biosynthesis for groWth.
Some glycerolipids of Saccharomyces cerevisiae are
knoWn. For example, US. Pat. No. 5,057,419 is entitled

of dihydroxy acetone phosphate acyltransferase indicates a
common gene” discloses the isolation of fourteen indepen
dent mutants defective in sn-glycerol-3-phosphate acyltrans
60

Genetically Engineered Plasmid and Organisms for the
production of SpecialiZed Oils. This patent discloses an
expression vector encoding a yeast delta-9 fatty acid desatu

ferase activity.
Chemical Abstracts, Vol. 115, Abstract 274626k, (1991),
“Acyl CoA-cholesterol acyltransferase (ACAT) inhibitors
from microbial and plant lipids” discloses that enZyme

rase enZyme Which functions in a yeast cell to induce or

enhance oil production. The overproduction of delta-9
desaturase by the cells leads to the production of abnormally
high levels of unsaturated fatty acids in the cell membrane.

“Mutants of Saccharomyces cerevisiae defective in

65

ACAT, responsible for absorption of cholesterol by the
intestinal epithelium is inhibited by fatty acid-like sub
stances obtained from enZymatic degradation products of
microbial and plant products.

5,869,304
4

3

YEp434 and inserted into the BglII site of p411. The ability

Chemical Abstracts, Vol. 114, Abstract 38917q, (1991), is
directed to “Genetic and biochemical studies of sn-glycerol

of plasmids to confer an Lcb+ phenotype on Lcb‘ strain 1A4

3-phosphate acyltransferase in Saccharomyces cerevisiae”.
Chemical Abstracts, Vol. 117, Abstract 167433q, (1992),
“The acyl dihydroXyacetone phosphate pathWay enZymes

is indicated. pN57 and pN15 are integrating vectors carrying
the SLC1 gene retrieved from strain 1A4 using pRS305.
Restriction endonuclease sites are: B, BamHI; B-Sa,

for glycerolipid biosynthesis are present in the yeast Sac
charomyces cerevisiae” discloses studies of the acyl dihy

BamHI-Sau3A1 junction; Bg, BglII; E, EcoRI; H, HindIII;
Nh, NheI; Ns, NsiI; S, SalI.

droXyacetone phosphate pathWay enZymes for glycerolipid

FIG. 2 shoWs the nucleotide sequence of SLC1. ShoWn

biosynthesis. This pathWay is used in yeast Saccharomyces
cerevisiae non-ether glycerolipid synthesis.

beloW the SLC1 nucleotide sequence (SEQ ID NO:1) is the
protein sequence. A membrane spanning domain is under
lined. N-linked glycosylation sites are indicated by brackets,
and putative N-myristoylation sites are indicated by paren

10

There is a need in the art for a knowledge of the SLC1
gene of Saccharomyces cerevisiae and its use to construct

economically and dietetically important plants, such as
seeds, from Which cooking oils are obtained Which have
fatty acids With optimal bene?ts, as Well as better storage
properties. Likewise, there is a need to produce animals

Whose meat products Would contain glycerolipids With fatty
acids having different degrees of saturation and/or chain
length. Such changes improve the ?avor and storage prop
erties and reduce adverse effects on humans, for example, by
reducing the percentage of polyunsaturated fatty acids. The

15

start codon are double underlined. Nucleotide 131 is
mutated from an A to a T in the SLC1-1 suppressor allele

(shoWn in bold).
FIG. 3 shoWs protein homology. The SLC1 protein
20

CLUSTAL (39). Amino acid residues identical in the three
25

An object of the present invention is to provide a tech

nique for specifying the fatty acid at the sn2 position of

acylglycerol lipids.
The method for specifying a fatty acid at the sn2 position

30

of acylglycerol lipids includes (a) transfecting a vector
including the SLC1 gene or a variant thereof into embryonic

biological material, and (b) alloWing the SLC1 gene to
replicate to direct fatty acid at the sn2 position of acylglyc
erol lipids. The biological material may be plant or animal

35

embryonic material.
The invention provides for isolation and characteriZation
of the SLC1 gene of Saccharomyces cerevisiae. Also pro
vided for is an isolated SLC1 gene and a probe for its
detection.

In an alternative embodiment, the invention provides for

probe for isolation of homologous gene sequences in other
organisms. The probe may be labeled by methods knoWn in
45

The invention provides for use of the SLC1 gene to

mRNA concentration. Molecular Weight markers and their

With fatty acids having different degrees of saturation and/or
chain length. Such changes improve the ?avor and storage
55

BRIEF DESCRIPTION OF DRAWINGS
60

the original insert are shoWn as is 411i#3, Which carries an

unspeci?ed 500-bp Sau3A1 fragment obtained from

grams. Panel B, as in panel A, but after transfer of the RNA
to the membrane, the membrane Was divided, and each
section Was hybridiZed separately With a riboprobe as indi
cated beloW each lane. Panel C, restriction map of analyZed
region shoWing the location and 5‘ to 3‘ direction of the
riboprobes. Open reading frames are shoWn as an open boX.
The 3‘ end of ORFX has not been determined as indicated by
the dotted line. The inverted triangle indicates the location of
the SLC1-1 suppressor mutation. Wavy lines denote the
deduced locations of the tWo 1.4-kb overlapping transcripts
described in the teXt. The siZe and orientation of riboprobes
(PROBES) are indicated. Restriction endonuclease sites are:

locus and plasmid subclones. The location of the SLC1 open
reading frame is denoted by the open arroW. p411 is plasmid
YEp434 carrying an 8.5-kb DNA fragment that contains the
SLC1-1 suppressor allele. Only the insert portion of each

plasmid is shoWn. Derivatives of p411 carrying a portion of

FIGS. 6A—C shoWs an analysis of SLC1 transcription by

siZe in kilobases are indicated at the side of the autoradio

have fatty acids With optimal bene?ts, as Well as better
storage properties. LikeWise, there is a need to produce
animals Whose meat products Would contain glycerolipids

FIG. 1 shoWs a restriction map of the SLC1 chromosomal

DNA inserts (30). Vertical lines indicate EcoRI or HindIII
restriction sites used to order and overlap )» clones. Unor
dered restriction fragments are bound by short vertical lines.
The alignment of two 9» clones, 3769 and 2328, and the S.
cerevisiae DNA insert in p411 is shoWn.

reaction included an LYS2 probe as an internal control for

such as seeds from Which cooking oils are obtained Which

eXample, by reducing the percentage of polyunsaturated
fatty acids.

coli strain J C201, carrying a temperature-sensitive mutation
in the plsC gene, Was transformed With the vector pRS315,
or the vector carrying a 4.15 -kb BamHI fragment containing
the yeast Wild type SLC1+ gene, or the suppressor allele
SLC1-1. Colonies of each type of transformant Were
streaked onto LB plates and tested for groWth at the indi
cated temperature. The length of incubation in hours is
indicated.
FIG. 5 shoWs the chromosomal location of SLC1. A
restriction map of a portion of the left arm of chromosome
IV is depicted at the top of the ?gure. The map Was

Northern blot hybridiZation. Panel A, each hybridiZation

construct economically and dietetically important plants,

properties and reduce adverse effects on humans, for

proteins are indicated by an asterisk beloW the sequence;
similar residues are indicated by a dot.
FIG. 4 shoWs SLC1 gene complements E. coli mutant. E.

constructed by overlapping )» clones carrying S. cerevisiae
40

use of the SLC1 gene of Saccharomyces cerevisiae as a

the art.

sequence (SEQ ID NO: 2) Was aligned With the E. coli PlsC

protein (PLSC) (SEQ ID NO:3) and the S. typhimurium parF
protein (PARF) (SEQ IS NO:4) using the program

present invention provides these bene?ts and overcomes the
de?ciencies and lack of knoWledge of the prior art.
DISCLOSURE OF THE INVENTION

theses. A start codon for ORFX is indicated by the CAT
sequence upstream of the SLC1 start codon. Putative
inositol/choline response elements upstream of the SLC1

A, AatII; Bg, BglII; E, EcoRI; H, HindIII; Hf, Hin?; Ns,
Nsil; RV, EcoRV.
FIGS. 7A—C shoWs construction of an SLC1 deletion
65

strain. Panel A, diagram of the slc1A1::URA3 deletion allele
described under “Experimental Procedures.” Panel B,
Southern blot analysis of the SLC1 locus in diploid strains

